All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Paradigm Biopharmaceuticals Limited market cap

Paradigm Biopharmaceuticals Limited volume of trade today and historical data of Paradigm Biopharmaceuticals Limited capitalization since start date of trade of PAR.AX stocks.
Add to widgets
Added to widgets

Paradigm Biopharmaceuticals Limited capitalization

Today's market capitalization for Paradigm Biopharmaceuticals Limited is 295 225 760 Aussie dollar.
+14 399 936 $ (+5.13%)
change of capitalization since yesterday

Every day, we record a change in Paradigm Biopharmaceuticals Limited capitalization. Paradigm Biopharmaceuticals Limited capitalization today is considered as the sum of all stock quote Paradigm Biopharmaceuticals Limited coins issued. Paradigm Biopharmaceuticals Limited capitalization is open information. Paradigm Biopharmaceuticals Limited capitalization = 295 225 760 US dollars.

Paradigm Biopharmaceuticals Limited volume of trade

Today's Paradigm Biopharmaceuticals Limited volume of trade is 288 893 Aussie dollar.
+236 840 $ (+455%)
change of volume of trade since yesterday

Paradigm Biopharmaceuticals Limited trading volume today is 288 893 US dollars. Paradigm Biopharmaceuticals Limited trading chart is on our website for every day. Paradigm Biopharmaceuticals Limited trading helds on many stock quote exchanges in real time, we show the daily trading volume of Paradigm Biopharmaceuticals Limited. Paradigm Biopharmaceuticals Limited capitalization has increased by $ 14 399 936.

Show:
to

Paradigm Biopharmaceuticals Limited market cap chart

Paradigm Biopharmaceuticals Limited capitalization on a graph by years. -4.91% per week - a change in the market capitalization of Paradigm Biopharmaceuticals Limited. The change in Paradigm Biopharmaceuticals Limited capitalization per month is 0%. Paradigm Biopharmaceuticals Limited capitalization has increased compared to yesterday.

Week Month 3 months Year 3 years

Paradigm Biopharmaceuticals Limited capitalization history

Date Capitalization
Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
04/05/2023 295 225 760 $
03/05/2023 280 825 824 $
02/05/2023 287 881 728 $
01/05/2023 287 881 728 $
28/04/2023 283 648 160 $
27/04/2023 292 115 264 $
26/04/2023 310 460 704 $

Paradigm Biopharmaceuticals Limited volume chart

Week Month 3 months Year 3 years

Paradigm Biopharmaceuticals Limited volume history data

Date Volume (24h)
Volume of trade of Paradigm Biopharmaceuticals Limited - total sum in US dollars for all deals with PAR.AX stocks bought and sold during selected date.
04/05/2023 288 893 $
03/05/2023 52 053 $
02/05/2023 452 681 $
01/05/2023 116 679 $
28/04/2023 20 979 $
27/04/2023 260 461 $
26/04/2023 111 956 $

Paradigm Biopharmaceuticals Limited capitalization amounted to 295 225 760 US dollars at 04/05/2023. Paradigm Biopharmaceuticals Limited capitalization is equal to 280 825 824 US dollars at 03/05/2023. 02/05/2023 Paradigm Biopharmaceuticals Limited capitalization amounted to 287 881 728 US dollars. Paradigm Biopharmaceuticals Limited market capitalization at 01/05/2023 is equal to 287 881 728 US dollars.

28/04/2023 Paradigm Biopharmaceuticals Limited capitalization amounted to 283 648 160 US dollars. The market capitalization of Paradigm Biopharmaceuticals Limited amounted to 292 115 264 US dollars at 27/04/2023. Paradigm Biopharmaceuticals Limited capitalization is equal to 310 460 704 US dollars at 26/04/2023.

Paradigm Biopharmaceuticals Limited capitalization is 295 225 760 $ now. Market capitalization of Paradigm Biopharmaceuticals Limited changed by +5.13% since yesterday. Today's volume of trade of PAR.AX stocks was 288 893 $. PAR.AX volume of trade amount changed to +455% since yesterday.

Paradigm Biopharmaceuticals Limited stocks data

Paradigm Biopharmaceuticals Limited financials